David H Liang, MD
Cardiovascular Disease (Cardiology) · Los Angeles
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 5
Offices
5 locations · USC Care Medical Group Inc · Sutter Bay Medical Foundation
Looking this up.
Hospitals listed: California Pacific Medical Center- Van Ness Campus · Hoag Memorial Hospital Presbyterian · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Liang’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G69354 · Current
Licensed to practise in California · since 1990 · expires 2027-09-30 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- Hoag Memorial Hospital PresbyterianNewport Beach, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Hoag Memorial Hospital Presbyterian, which runs 2 hospitalsPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.5 (4 to 7.01) · 4,199 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 2.98 (1.7 to 4.26) · 1,783 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.347, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.08, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.424, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Hoag Memorial Hospital Presbyterian
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 0 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.5 (4 to 7.01) · 4,199 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.98 (1.7 to 4.26) · 1,783 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.347 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.08 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.424 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.38 (0.66 to 2.11) · 4,300 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.77 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 177.94 (136.85 to 219.02) · 205 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 147 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 181 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.6 · 1,342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12 · 640 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 8,076 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.33) · 16,407 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.07 to 0.4) · 17,438 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.53 (1.38 to 3.69) · 3,951 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.19 (5.21 to 13.18) · 1,671 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.57 (0.98 to 6.16) · 1,736 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.32 (0 to 2.65) · 1,305 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 0.77) · 13,612 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.746 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.729 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.548 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.6 · 439 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 1,296 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -10.1 · 348 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -30.2 · 1,019 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8.5 · 1,378 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.9 · 1,534 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4 to 6.6) · 628 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.9 (8.2 to 12) · 628 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 8.3 · 177 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.4 · 285 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.3 (11.1 to 18.3) · 1,096 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 1,170 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,329 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 81% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$13,134
Medicare paid this office $13,134 for 160 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 34 | $2,207 | $55 |
| Ultrasound of heart with probe in esophagus, with report | 22 | $2,145 | $93 |
| Short return visit (20+ min) | 33 | $2,105 | $53 |
| Short return visit | 51 | $1,325 | $23 |
| Return visit (30+ min) | 11 | $837 | $76 |
See all 7 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 34 | $2,207 | $55 |
| Ultrasound of heart with probe in esophagus, with report | 22 | $2,145 | $93 |
| Short return visit (20+ min) | 33 | $2,105 | $53 |
| Short return visit | 51 | $1,325 | $23 |
| Return visit (30+ min) | 11 | $837 | $76 |
| Ultrasound of heart blood flow, valves and chambers | 11 | $172 | $16 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $102 | $6 |
Who their Medicare patients are
160 Original Medicare patients in 2024. Average age 73 · Under 65 11% · 85 and older 11% · Women 49% · Also on Medicaid 13% · Health risk score 1.54. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 74% · Atrial fibrillation 43% · Coronary heart disease 40% · Heart failure 35% · Chronic kidney disease 25% · Depression 24% · Diabetes 23% · COPD 21% · Cancer 13% · Stroke 11%.
The office billed $101,379, Medicare allowed $17,349 and paid $13,134; for 270 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 160 | 270 | 73 | 1.54 | $101,379 | $13,134 |
| 2023 | 158 | 307 | 74 | 1.56 | $243,070 | $17,666 |
| 2022 | 146 | 329 | 75 | 1.77 | $188,410 | $18,343 |
| 2021 | 339 | 639 | 74 | 1.63 | $251,315 | $30,495 |
| 2020 | 205 | 424 | 74 | 1.87 | $222,319 | $18,406 |
| 2019 | 663 | 1,207 | 74 | 2.20 | $489,791 | $51,109 |
| 2018 | 1,085 | 2,020 | 74 | 2.10 | $602,576 | $91,543 |
| 2017 | 1,537 | 2,788 | 74 | 2.05 | $756,629 | $124,849 |
| 2016 | 1,489 | 2,848 | 75 | 1.93 | $759,080 | $128,694 |
| 2015 | 1,254 | 2,373 | 74 | 2.03 | $548,298 | $102,265 |
| 2014 | 1,028 | 2,013 | 73 | 1.85 | $406,997 | $76,570 |
| 2013 | 1,049 | 2,053 | 73 | 1.77 | $386,157 | $68,631 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Ultrasound of heart with probe in esophagus, with report | 23 | $2,350 | $98 |
| Short return visit (20+ min) | 33 | $1,972 | $56 |
| Return visit (30+ min) | 24 | $1,948 | $75 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $1,671 | $45 |
| External shock to heart to regulate heart beat | 11 | $1,177 | $98 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,058 | $76 |
| Short return visit | 30 | $1,034 | $29 |
| 3d radiographic procedure with computerized image postprocessing | 11 | $387 | $35 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $312 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 18 | $54 | $3 |
2022: 11 services
| Short return visit (20+ min) | 41 | $2,802 | $54 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $1,866 | $32 |
| Ultrasound of heart with probe in esophagus, with report | 15 | $1,494 | $100 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,171 | $90 |
| Hospital discharge day management, 30 minutes or less | 15 | $1,032 | $64 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 16 | $1,023 | $64 |
| New patient visit (30+ min) | 13 | $882 | $68 |
| Short return visit | 24 | $787 | $30 |
| 3d radiographic procedure with computerized image postprocessing | 14 | $499 | $36 |
| Ultrasound of heart blood flow, valves and chambers | 14 | $233 | $17 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $49 | $3 |
2021: 15 services
| Short return visit (20+ min) | 104 | $7,251 | $59 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 80 | $4,512 | $55 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $2,371 | $35 |
| Short return visit | 64 | $1,753 | $24 |
| Ultrasound of heart with probe in esophagus, with report | 17 | $1,718 | $101 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 25 | $1,518 | $61 |
| Hospital discharge day management, 30 minutes or less | 12 | $1,019 | $68 |
| New patient visit (30+ min) | 14 | $1,006 | $72 |
| New patient visit (15+ min) | 16 | $704 | $44 |
| Ultrasound of heart, follow-up | 21 | $402 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 22 | $388 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 22 | $274 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 17 | $240 | $14 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 25 | $147 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 28 | $76 | $3 |
2020: 8 services
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 26 | $4,822 | $36 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 71 | $3,198 | $45 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 19 | $2,092 | $95 |
| Short return visit | 50 | $1,354 | $23 |
| Hospital discharge day management, 30 minutes or less | 14 | $1,112 | $69 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 13 | $648 | $50 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $160 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $112 | $10 |
2019: 17 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 309 | $19,049 | $60 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 88 | $5,447 | $62 |
| Short return visit | 138 | $4,114 | $21 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 24 | $2,735 | $36 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 25 | $2,424 | $90 |
| Ultrasound of heart with probe in esophagus, with report | 21 | $2,180 | $99 |
| External shock to heart to regulate heart beat | 17 | $1,960 | $85 |
| Hospital discharge day management, 30 minutes or less | 26 | $1,837 | $66 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 82 | $1,526 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 82 | $1,028 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 14 | $943 | $67 |
| Ultrasound of heart blood flow, valves and chambers | 51 | $826 | $16 |
| New patient visit (30+ min) | 12 | $686 | $57 |
| Ultrasound of heart, follow-up | 25 | $568 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 65 | $188 | $3 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 12 | $133 | $11 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 17 | $107 | $6 |
2018: 16 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 658 | $40,568 | $60 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 56 | $11,296 | $202 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 163 | $9,598 | $59 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 25 | $5,700 | $35 |
| Ultrasound of heart with probe in esophagus, with report | 39 | $3,998 | $98 |
| Short return visit | 121 | $2,903 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 156 | $2,772 | $18 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $2,515 | $90 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 32 | $1,973 | $62 |
| Hospital discharge day management, 30 minutes or less | 19 | $1,872 | $67 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 155 | $1,866 | $12 |
| Ultrasound of heart, follow-up | 58 | $1,398 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 84 | $1,299 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 112 | $314 | $3 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 38 | $264 | $7 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 11 | $121 | $11 |
2017: 16 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 981 | $54,720 | $52 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 102 | $20,786 | $202 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 206 | $12,572 | $61 |
| Short return visit | 173 | $6,173 | $20 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 33 | $5,100 | $35 |
| Ultrasound of heart with probe in esophagus, with report | 41 | $3,947 | $96 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 190 | $3,500 | $18 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 28 | $2,960 | $90 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 191 | $2,391 | $12 |
| Hospital discharge day management, 30 minutes or less | 33 | $2,319 | $66 |
| Ultrasound of heart blood flow, valves and chambers | 125 | $1,848 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 35 | $1,787 | $51 |
| New patient visit (30+ min) | 12 | $815 | $68 |
| Ultrasound of heart, follow-up | 33 | $791 | $21 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 159 | $419 | $3 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 17 | $106 | $6 |
2016: 20 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 917 | $51,060 | $53 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 88 | $17,620 | $200 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 217 | $12,470 | $57 |
| Ultrasound of heart with probe in esophagus, with report | 65 | $7,407 | $109 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 36 | $6,836 | $35 |
| Short return visit | 174 | $6,673 | $20 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 38 | $4,315 | $88 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 201 | $3,702 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 202 | $2,412 | $12 |
| Hospital discharge day management, 30 minutes or less | 31 | $2,367 | $66 |
| Initial hospital care with same-day admission and discharge with straightforward or low level of medical decision making, per day at least 45 minutes | 15 | $1,899 | $119 |
| Ultrasound of heart blood flow, valves and chambers | 112 | $1,685 | $15 |
| Initial hospital observation care per day, typically 30 minutes | 19 | $1,679 | $88 |
| External shock to heart to regulate heart beat | 12 | $1,486 | $99 |
| Hospital observation care on day of discharge | 21 | $1,383 | $66 |
| New patient visit (30+ min) | 21 | $1,288 | $61 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 15 | $859 | $57 |
| Ultrasound of heart, follow-up | 35 | $820 | $23 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 165 | $455 | $3 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 15 | $105 | $7 |
2015: 17 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 859 | $48,590 | $53 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 154 | $9,172 | $59 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 35 | $7,173 | $34 |
| Short return visit | 153 | $5,922 | $21 |
| Ultrasound of heart with probe in esophagus during surgery on heart or great blood vessels with report | 26 | $5,230 | $201 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 44 | $4,643 | $88 |
| Ultrasound of heart with probe in esophagus, with report | 32 | $3,378 | $106 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 152 | $2,928 | $19 |
| Hospital discharge day management, 30 minutes or less | 37 | $2,876 | $65 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 152 | $1,893 | $12 |
| External shock to heart to regulate heart beat | 11 | $1,513 | $108 |
| Ultrasound of heart blood flow, valves and chambers | 72 | $1,146 | $16 |
| New patient visit (30+ min) | 12 | $748 | $62 |
| Ultrasound of heart, follow-up | 33 | $745 | $23 |
| Short return visit (20+ min) | 12 | $545 | $45 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 100 | $294 | $3 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 17 | $112 | $7 |
2014: 17 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 631 | $35,619 | $52 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 141 | $7,887 | $56 |
| Ultrasound of heart with probe in esophagus, with report | 61 | $5,940 | $93 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 33 | $5,101 | $35 |
| Short return visit | 131 | $4,837 | $20 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 32 | $3,204 | $89 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 137 | $2,513 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 137 | $1,627 | $12 |
| Hospital discharge day management, 30 minutes or less | 18 | $1,244 | $65 |
| Ultrasound of heart blood flow, valves and chambers | 67 | $1,045 | $16 |
| Short return visit (20+ min) | 21 | $926 | $39 |
| New patient visit (30+ min) | 12 | $810 | $68 |
| 3d radiographic procedure with computerized image postprocessing | 17 | $639 | $35 |
| Ultrasound of heart, follow-up | 21 | $507 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 54 | $469 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 120 | $361 | $3 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $132 | $8 |
2013: 16 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 568 | $31,062 | $52 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 179 | $10,286 | $57 |
| Ultrasound of heart with probe in esophagus, with report | 85 | $7,751 | $89 |
| Short return visit | 112 | $4,173 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 174 | $3,166 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 175 | $2,111 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 127 | $1,954 | $15 |
| 3d radiographic procedure with computerized image postprocessing | 52 | $1,754 | $34 |
| Short return visit (20+ min) | 25 | $1,057 | $39 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 101 | $927 | $7 |
| New patient visit (30+ min) | 15 | $847 | $56 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 178 | $567 | $3 |
| Ultrasound of heart, follow-up | 25 | $556 | $21 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 16 | $363 | $23 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $118 | $7 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 12 | $75 | $6 |
Medicaid work
$476 in 2021
Medicaid paid $476 for 29 billed services this clinician did in 2021, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit | 29 | $476 |
| 2021 | 29 | 1 | 13 | $476 |
| 2020 | 12 | 1 | 12 | $406 |
| 2019 | 89 | 1 | 28 | $4,697 |
| 2018 | 245 | 1 | 33 | $12,208 |
See the largest Medicaid services in earlier years
2020
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 12 | $406 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 89 | $4,697 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 245 | $12,208 |
Drugs they prescribed that Part D paid
$726,474
Pharmacies billed $726,474 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (136 of 2,907) in 2024. A higher opioid share than 9 in 10 peers; the typical cardiology clinician is at 0%. Long-acting opioids: 28% of their opioid prescriptions.
2,461 generic and fewer than 11 brand-name prescriptions · $726,474 in drug cost · 85 antibiotic prescriptions to 46 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 149 | $206,515 | $1,386 |
| Camzyos | 25 | $199,198 | $7,968 |
| Jardiance | 40 | $55,042 | $1,376 |
| Xarelto | 25 | $37,674 | $1,507 |
| Ozempic | 19 | $22,375 | $1,178 |
See all 61 drugs
| Eliquis | 149 | $206,515 | $1,386 |
| Camzyos | 25 | $199,198 | $7,968 |
| Jardiance | 40 | $55,042 | $1,376 |
| Xarelto | 25 | $37,674 | $1,507 |
| Ozempic | 19 | $22,375 | $1,178 |
| Repatha Sureclick | 25 | $20,425 | $817 |
| Praluent | 20 | $13,565 | $678 |
| Eplerenone | 49 | $4,818 | $98 |
| Amiodarone | 39 | $3,141 | $81 |
| Valsartan | 36 | $2,640 | $73 |
| Celecoxib | 12 | $2,531 | $211 |
| Ondansetron Odt | 12 | $2,260 | $188 |
| Hydrocodone-Acetaminophen | 49 | $2,240 | $46 |
| Metoprolol | 124 | $2,162 | $17 |
| Irbesartan | 86 | $1,732 | $20 |
| Carvedilol | 121 | $1,712 | $14 |
| Losartan | 109 | $1,668 | $15 |
| Gabapentin | 59 | $1,531 | $26 |
| Rosuvastatin | 82 | $1,518 | $19 |
| Atorvastatin | 148 | $1,488 | $10 |
| Flecainide Acetate | 28 | $1,450 | $52 |
| Amlodipine Besylate | 114 | $1,433 | $13 |
| Paxlovid | 20 | $1,429 | $71 |
| Mycophenolate Mofetil | 15 | $1,245 | $83 |
| Telmisartan | 18 | $923 | $51 |
| Methadone | 21 | $907 | $43 |
| Bupropion Xl | 20 | $895 | $45 |
| Pantoprazole | 46 | $841 | $18 |
| Lisinopril | 54 | $808 | $15 |
| Clopidogrel | 30 | $719 | $24 |
| Oxycodone | 30 | $706 | $24 |
| Morphine Sulfate Er | 17 | $638 | $38 |
| Levothyroxine | 34 | $631 | $19 |
| Sucralfate | 12 | $614 | $51 |
| Warfarin | 39 | $573 | $15 |
| Tamsulosin | 27 | $571 | $21 |
| Omeprazole | 18 | $556 | $31 |
| Alprazolam | 20 | $524 | $26 |
| Metoprolol | 56 | $484 | $9 |
| Potassium Chloride | 20 | $478 | $24 |
| Furosemide | 56 | $465 | $8 |
| Atenolol | 33 | $439 | $13 |
| Ezetimibe | 20 | $429 | $21 |
| Spironolactone | 29 | $404 | $14 |
| Digoxin | 17 | $372 | $22 |
| Hydrochlorothiazide | 85 | $346 | $4 |
| Prednisone | 32 | $327 | $10 |
| Hydralazine | 21 | $314 | $15 |
| Cyclobenzaprine | 11 | $244 | $22 |
| Diltiazem 24hr Er (Cd) | 12 | $239 | $20 |
| Clonazepam | 23 | $223 | $10 |
| Allopurinol | 14 | $211 | $15 |
| Fluticasone Propionate | 16 | $207 | $13 |
| Nitroglycerin | 15 | $182 | $12 |
| Azithromycin | 26 | $170 | $7 |
| Escitalopram | 18 | $127 | $7 |
| Simvastatin | 22 | $100 | $5 |
| Famotidine | 11 | $97 | $9 |
| Montelukast | 12 | $92 | $8 |
| Metformin | 12 | $64 | $5 |
| Amoxicillin | 30 | $46 | $2 |
Year by year
| 2024 | 2,907 | 356 | 5% (136) | None | $726,474 |
| 2023 | 3,710 | 347 | 5% (187) | 15% | $747,734 |
| 2022 | 3,463 | 317 | 6% (213) | 14% | $722,233 |
| 2021 | 3,006 | 276 | 6% (187) | 14% | $882,547 |
| 2020 | 2,562 | 232 | 5% (139) | 16% | $677,474 |
| 2019 | 2,340 | 230 | 5% (118) | 18% | $326,228 |
| 2018 | 2,201 | 204 | 3% (75) | None | $315,444 |
| 2017 | 1,982 | 202 | 4% (87) | None | $404,640 |
| 2016 | 1,899 | 179 | 3% (57) | None | $220,178 |
| 2015 | 1,839 | 151 | 3% (61) | None | $223,152 |
| 2014 | 1,741 | 148 | 4% (68) | 24% | $238,743 |
| 2013 | 1,619 | 120 | 6% (92) | None | $257,691 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 72 drugs
| Eliquis | 210 | $254,977 | $1,214 |
| Xarelto | 36 | $57,651 | $1,601 |
| Jardiance | 30 | $50,741 | $1,691 |
| Repatha Sureclick | 34 | $38,458 | $1,131 |
| Farxiga | 17 | $24,005 | $1,412 |
| Ozempic | 21 | $19,309 | $919 |
| Dofetilide | 11 | $12,605 | $1,146 |
| Eplerenone | 56 | $9,811 | $175 |
| Movantik | 12 | $6,823 | $569 |
| Corlanor | 11 | $6,805 | $619 |
| Atrovent Hfa | 12 | $5,456 | $455 |
| Metoprolol | 199 | $5,170 | $26 |
| Colchicine | 24 | $4,510 | $188 |
| Valsartan | 43 | $3,744 | $87 |
| Flecainide Acetate | 46 | $3,722 | $81 |
| Gabapentin | 69 | $3,677 | $53 |
| Losartan | 111 | $2,998 | $27 |
| Irbesartan | 93 | $2,994 | $32 |
| Atorvastatin | 183 | $2,608 | $14 |
| Carvedilol | 123 | $2,229 | $18 |
| Amiodarone | 55 | $2,144 | $39 |
| Amlodipine Besylate | 141 | $2,036 | $14 |
| Warfarin | 77 | $1,827 | $24 |
| Rosuvastatin | 77 | $1,668 | $22 |
| Telmisartan | 24 | $1,658 | $69 |
| Celecoxib | 22 | $1,483 | $67 |
| Hydrocodone-Acetaminophen | 54 | $1,437 | $27 |
| Mycophenolate Mofetil | 19 | $1,384 | $73 |
| Atenolol | 66 | $1,380 | $21 |
| Levothyroxine | 55 | $1,309 | $24 |
| Diltiazem 24hr Er (Cd) | 28 | $1,152 | $41 |
| Potassium Chloride | 37 | $1,148 | $31 |
| Diclofenac | 18 | $1,128 | $63 |
| Morphine Sulfate Er | 31 | $1,079 | $35 |
| Furosemide | 107 | $1,042 | $10 |
| Pantoprazole | 62 | $1,028 | $17 |
| Oxycodone | 48 | $990 | $21 |
| Lisinopril | 77 | $925 | $12 |
| Prednisone | 56 | $849 | $15 |
| Tamsulosin | 32 | $824 | $26 |
| Spironolactone | 27 | $821 | $30 |
| Metoprolol | 73 | $820 | $11 |
| Ezetimibe | 18 | $814 | $45 |
| Omeprazole | 25 | $752 | $30 |
| Digoxin | 20 | $739 | $37 |
| Duloxetine | 11 | $717 | $65 |
| Fludrocortisone Acetate | 12 | $674 | $56 |
| Estradiol (Once Weekly) | 11 | $672 | $61 |
| Hydralazine | 27 | $648 | $24 |
| Benazepril | 15 | $637 | $42 |
| Hydrochlorothiazide | 117 | $635 | $5 |
| Oxycodone-Acetaminophen | 12 | $629 | $52 |
| Nitroglycerin | 13 | $618 | $48 |
| Clopidogrel | 18 | $554 | $31 |
| Bupropion Xl | 15 | $548 | $37 |
| Amoxicillin-Clavulanate Potass | 11 | $485 | $44 |
| Escitalopram | 28 | $475 | $17 |
| Methadone | 22 | $416 | $19 |
| Simvastatin | 31 | $399 | $13 |
| Paxlovid (Eua) | 31 | $320 | $10 |
| Famotidine | 15 | $289 | $19 |
| Alprazolam | 18 | $282 | $16 |
| Clonazepam | 14 | $280 | $20 |
| Tramadol | 18 | $254 | $14 |
| Triamterene-Hydrochlorothiazid | 11 | $252 | $23 |
| Montelukast | 12 | $226 | $19 |
| Allopurinol | 13 | $219 | $17 |
| Azithromycin | 20 | $128 | $6 |
| Metformin | 17 | $119 | $7 |
| Lorazepam | 12 | $92 | $8 |
| Amoxicillin | 28 | $46 | $2 |
| Naproxen | 12 | $27 | $2 |
2022: 74 drugs
| Eliquis | 155 | $190,529 | $1,229 |
| Xarelto | 49 | $67,884 | $1,385 |
| Repatha Sureclick | 36 | $36,706 | $1,020 |
| Trulicity | 14 | $22,879 | $1,634 |
| Jardiance | 14 | $22,212 | $1,587 |
| Ozempic | 24 | $21,552 | $898 |
| Eplerenone | 44 | $11,216 | $255 |
| Sildenafil Citrate | 11 | $5,466 | $497 |
| Metoprolol | 164 | $4,470 | $27 |
| Eszopiclone | 11 | $3,369 | $306 |
| Atorvastatin | 173 | $2,980 | $17 |
| Valsartan | 32 | $2,773 | $87 |
| Flecainide Acetate | 35 | $2,478 | $71 |
| Duloxetine | 13 | $2,454 | $189 |
| Irbesartan | 64 | $2,343 | $37 |
| Gabapentin | 63 | $2,217 | $35 |
| Rosuvastatin | 58 | $1,915 | $33 |
| Amiodarone | 41 | $1,902 | $46 |
| Propafenone | 15 | $1,795 | $120 |
| Morphine Sulfate Er | 35 | $1,754 | $50 |
| Hydrocodone-Acetaminophen | 81 | $1,749 | $22 |
| Mycophenolate Mofetil | 19 | $1,706 | $90 |
| Carvedilol | 98 | $1,664 | $17 |
| Ezetimibe | 14 | $1,605 | $115 |
| Telmisartan | 18 | $1,582 | $88 |
| Warfarin | 75 | $1,465 | $20 |
| Amlodipine Besylate | 133 | $1,429 | $11 |
| Labetalol | 11 | $1,295 | $118 |
| Diclofenac | 29 | $1,248 | $43 |
| Pantoprazole | 54 | $1,189 | $22 |
| Prednisone | 66 | $1,159 | $18 |
| Potassium Chloride | 33 | $1,152 | $35 |
| Lisinopril | 98 | $1,136 | $12 |
| Losartan | 77 | $1,076 | $14 |
| Levothyroxine | 44 | $1,064 | $24 |
| Sodium Chloride | 11 | $933 | $85 |
| Diltiazem 24hr Er (Cd) | 36 | $879 | $24 |
| Atenolol | 75 | $865 | $12 |
| Furosemide | 90 | $715 | $8 |
| Celecoxib | 13 | $700 | $54 |
| Oxycodone | 33 | $694 | $21 |
| Nitroglycerin | 21 | $640 | $30 |
| Metoprolol | 69 | $610 | $9 |
| Clopidogrel | 19 | $595 | $31 |
| Hydrochlorothiazide | 108 | $553 | $5 |
| Ondansetron Odt | 19 | $534 | $28 |
| Hydralazine | 16 | $524 | $33 |
| Bupropion Xl | 14 | $517 | $37 |
| Omeprazole | 19 | $514 | $27 |
| Azithromycin | 23 | $503 | $22 |
| Isosorbide Mononitrate Er | 22 | $498 | $23 |
| Tamsulosin | 21 | $433 | $21 |
| Chlorthalidone | 11 | $388 | $35 |
| Methadone | 22 | $361 | $16 |
| Benazepril | 13 | $352 | $27 |
| Alprazolam | 24 | $331 | $14 |
| Trazodone | 16 | $317 | $20 |
| Tramadol | 23 | $306 | $13 |
| Spironolactone | 23 | $285 | $12 |
| Simvastatin | 33 | $262 | $8 |
| Zolpidem | 16 | $229 | $14 |
| Digoxin | 11 | $214 | $19 |
| Triamterene-Hydrochlorothiazid | 11 | $202 | $18 |
| Montelukast | 13 | $193 | $15 |
| Allopurinol | 14 | $186 | $13 |
| Cephalexin | 17 | $182 | $11 |
| Lorazepam | 15 | $158 | $11 |
| Escitalopram | 14 | $156 | $11 |
| Clonazepam | 28 | $144 | $5 |
| Amoxicillin | 26 | $142 | $5 |
| Metformin | 17 | $136 | $8 |
| Topiramate | 11 | $94 | $9 |
| Sulfamethoxazole-Trimethoprim | 12 | $87 | $7 |
| Naproxen | 13 | $37 | $3 |
2021: 60 drugs
| Vyndamax | 13 | $412,164 | $31,705 |
| Eliquis | 168 | $172,490 | $1,027 |
| Xarelto | 58 | $63,714 | $1,099 |
| Repatha Sureclick | 14 | $11,225 | $802 |
| Eplerenone | 33 | $8,130 | $246 |
| Metoprolol | 153 | $4,818 | $31 |
| Flecainide Acetate | 30 | $4,527 | $151 |
| Valsartan | 29 | $3,240 | $112 |
| Atorvastatin | 134 | $2,680 | $20 |
| Gabapentin | 70 | $2,447 | $35 |
| Morphine Sulfate Er | 37 | $2,438 | $66 |
| Hydrocodone-Acetaminophen | 74 | $2,154 | $29 |
| Warfarin | 137 | $2,112 | $15 |
| Carvedilol | 104 | $2,092 | $20 |
| Irbesartan | 38 | $2,065 | $54 |
| Amiodarone | 28 | $1,995 | $71 |
| Telmisartan | 18 | $1,877 | $104 |
| Ezetimibe | 16 | $1,763 | $110 |
| Azithromycin | 15 | $1,610 | $107 |
| Rosuvastatin | 44 | $1,477 | $34 |
| Losartan | 75 | $1,460 | $19 |
| Mycophenolate Mofetil | 25 | $1,445 | $58 |
| Nitroglycerin | 17 | $1,290 | $76 |
| Propafenone | 16 | $1,122 | $70 |
| Lisinopril | 80 | $1,091 | $14 |
| Potassium Chloride | 24 | $1,024 | $43 |
| Sildenafil Citrate | 19 | $1,003 | $53 |
| Prednisone | 51 | $957 | $19 |
| Diltiazem 24hr Er (Cd) | 26 | $954 | $37 |
| Chlorthalidone | 15 | $898 | $60 |
| Clopidogrel | 32 | $898 | $28 |
| Amlodipine Besylate | 94 | $890 | $9 |
| Pantoprazole | 45 | $886 | $20 |
| Furosemide | 76 | $861 | $11 |
| Bupropion | 16 | $860 | $54 |
| Levothyroxine | 33 | $805 | $24 |
| Diclofenac | 19 | $773 | $41 |
| Omeprazole | 29 | $741 | $26 |
| Atenolol | 61 | $701 | $11 |
| Metoprolol | 57 | $692 | $12 |
| Spironolactone | 26 | $635 | $24 |
| Isosorbide Mononitrate Er | 27 | $560 | $21 |
| Hydrochlorothiazide | 91 | $555 | $6 |
| Ondansetron Odt | 24 | $515 | $21 |
| Tamsulosin | 25 | $510 | $20 |
| Oxycodone | 25 | $501 | $20 |
| Benazepril | 20 | $419 | $21 |
| Alprazolam | 20 | $374 | $19 |
| Simvastatin | 37 | $371 | $10 |
| Trazodone | 15 | $364 | $24 |
| Triamterene-Hydrochlorothiazid | 17 | $330 | $19 |
| Clonazepam | 11 | $290 | $26 |
| Tramadol | 21 | $290 | $14 |
| Zolpidem | 23 | $191 | $8 |
| Lorazepam | 22 | $180 | $8 |
| Allopurinol | 11 | $160 | $15 |
| Metformin | 19 | $157 | $8 |
| Cephalexin | 16 | $88 | $6 |
| Methadone | 12 | $79 | $7 |
| Amoxicillin | 24 | $55 | $2 |
2020: 60 drugs
| Vyndamax | 16 | $320,945 | $20,059 |
| Eliquis | 107 | $107,439 | $1,004 |
| Xarelto | 75 | $68,713 | $916 |
| Jardiance | 11 | $21,069 | $1,915 |
| Eplerenone | 26 | $9,692 | $373 |
| Praluent | 11 | $9,205 | $837 |
| Repatha Sureclick | 13 | $8,978 | $691 |
| Flecainide Acetate | 39 | $5,365 | $138 |
| Metoprolol | 122 | $3,747 | $31 |
| Valsartan | 35 | $3,531 | $101 |
| Warfarin | 196 | $2,524 | $13 |
| Atorvastatin | 113 | $2,421 | $21 |
| Amiodarone | 20 | $2,047 | $102 |
| Gabapentin | 66 | $2,041 | $31 |
| Hydrocodone-Acetaminophen | 69 | $2,018 | $29 |
| Lidocaine | 12 | $2,011 | $168 |
| Carvedilol | 94 | $1,981 | $21 |
| Losartan | 84 | $1,944 | $23 |
| Ezetimibe | 19 | $1,942 | $102 |
| Telmisartan | 19 | $1,743 | $92 |
| Mycophenolate Mofetil | 24 | $1,676 | $70 |
| Propafenone | 15 | $1,579 | $105 |
| Rosuvastatin | 31 | $1,435 | $46 |
| Nitroglycerin | 20 | $1,261 | $63 |
| Potassium Chloride | 26 | $1,047 | $40 |
| Omeprazole | 40 | $954 | $24 |
| Levothyroxine | 34 | $926 | $27 |
| Furosemide | 60 | $888 | $15 |
| Duloxetine | 13 | $883 | $68 |
| Bupropion | 22 | $821 | $37 |
| Tramadol Hcl Er | 12 | $802 | $67 |
| Lisinopril | 53 | $773 | $15 |
| Spironolactone | 29 | $753 | $26 |
| Metoprolol | 46 | $690 | $15 |
| Isosorbide Mononitrate Er | 19 | $675 | $36 |
| Amlodipine Besylate | 77 | $668 | $9 |
| Irbesartan | 18 | $638 | $35 |
| Atenolol | 47 | $631 | $13 |
| Hydrochlorothiazide | 72 | $596 | $8 |
| Tamsulosin | 17 | $585 | $34 |
| Morphine Sulfate Er | 23 | $575 | $25 |
| Celecoxib | 11 | $575 | $52 |
| Clopidogrel | 18 | $556 | $31 |
| Escitalopram | 26 | $543 | $21 |
| Simvastatin | 37 | $533 | $14 |
| Trazodone | 13 | $383 | $29 |
| Triamterene-Hydrochlorothiazid | 17 | $348 | $20 |
| Alprazolam | 19 | $323 | $17 |
| Pantoprazole | 27 | $231 | $9 |
| Prednisone | 16 | $230 | $14 |
| Allopurinol | 16 | $203 | $13 |
| Benazepril | 15 | $203 | $14 |
| Lorazepam | 14 | $169 | $12 |
| Lovastatin | 13 | $164 | $13 |
| Zolpidem | 33 | $158 | $5 |
| Jantoven | 11 | $124 | $11 |
| Metformin | 14 | $110 | $8 |
| Methadone | 17 | $97 | $6 |
| Topiramate | 16 | $97 | $6 |
| Butalbital-Acetaminophen-Caffe | 12 | $95 | $8 |
2019: 51 drugs
| Xarelto | 57 | $57,020 | $1,000 |
| Eliquis | 70 | $53,908 | $770 |
| Praluent | 27 | $35,776 | $1,325 |
| Eplerenone | 36 | $11,783 | $327 |
| Combivent Respimat | 11 | $6,459 | $587 |
| Repatha Sureclick | 11 | $5,297 | $482 |
| Flecainide Acetate | 39 | $4,151 | $106 |
| Metoprolol | 77 | $3,802 | $49 |
| Atorvastatin | 127 | $3,135 | $25 |
| Hydrocodone-Acetaminophen | 67 | $2,348 | $35 |
| Gabapentin | 44 | $1,790 | $41 |
| Amiodarone | 33 | $1,767 | $54 |
| Warfarin | 136 | $1,740 | $13 |
| Valsartan | 28 | $1,672 | $60 |
| Carvedilol | 91 | $1,416 | $16 |
| Duloxetine | 12 | $1,288 | $107 |
| Losartan | 78 | $1,247 | $16 |
| Ezetimibe | 12 | $1,216 | $101 |
| Potassium Chloride | 24 | $1,171 | $49 |
| Irbesartan | 24 | $1,127 | $47 |
| Nitroglycerin | 20 | $1,006 | $50 |
| Spironolactone | 41 | $959 | $23 |
| Furosemide | 61 | $884 | $14 |
| Ventolin Hfa | 15 | $857 | $57 |
| Rosuvastatin | 24 | $811 | $34 |
| Lisinopril | 48 | $764 | $16 |
| Tramadol Hcl Er | 12 | $751 | $63 |
| Amlodipine Besylate | 62 | $728 | $12 |
| Clopidogrel | 33 | $728 | $22 |
| Morphine Sulfate Er | 20 | $694 | $35 |
| Omeprazole | 33 | $670 | $20 |
| Levothyroxine | 19 | $626 | $33 |
| Atenolol | 53 | $626 | $12 |
| Simvastatin | 41 | $589 | $14 |
| Escitalopram | 28 | $562 | $20 |
| Tamsulosin | 16 | $543 | $34 |
| Hydrochlorothiazide | 67 | $529 | $8 |
| Metoprolol | 44 | $470 | $11 |
| Azithromycin | 21 | $385 | $18 |
| Alprazolam | 17 | $381 | $22 |
| Triamterene-Hydrochlorothiazid | 20 | $371 | $19 |
| Zolpidem | 22 | $318 | $14 |
| Pantoprazole | 19 | $313 | $16 |
| Isosorbide Mononitrate Er | 13 | $281 | $22 |
| Benazepril | 15 | $270 | $18 |
| Allopurinol | 15 | $209 | $14 |
| Paroxetine | 13 | $188 | $14 |
| Dicyclomine | 11 | $176 | $16 |
| Lorazepam | 15 | $130 | $9 |
| Metformin | 16 | $111 | $7 |
| Amoxicillin | 14 | $43 | $3 |
2018: 45 drugs
| Xarelto | 55 | $52,297 | $951 |
| Praluent | 41 | $50,891 | $1,241 |
| Eliquis | 50 | $38,154 | $763 |
| Eplerenone | 30 | $5,274 | $176 |
| Metoprolol | 69 | $3,382 | $49 |
| Atorvastatin | 132 | $2,741 | $21 |
| Valsartan | 41 | $2,666 | $65 |
| Ventolin Hfa | 38 | $2,118 | $56 |
| Warfarin | 83 | $1,694 | $20 |
| Celecoxib | 15 | $1,625 | $108 |
| Potassium Chloride | 34 | $1,473 | $43 |
| Gabapentin | 38 | $1,317 | $35 |
| Oxycodone | 13 | $1,302 | $100 |
| Hydrocodone-Acetaminophen | 36 | $1,279 | $36 |
| Losartan | 90 | $1,123 | $12 |
| Nitroglycerin Patch | 12 | $997 | $83 |
| Carvedilol | 94 | $983 | $10 |
| Tamsulosin | 24 | $924 | $38 |
| Morphine Sulfate Er | 12 | $876 | $73 |
| Amiodarone | 17 | $725 | $43 |
| Flecainide Acetate | 12 | $721 | $60 |
| Spironolactone | 30 | $669 | $22 |
| Furosemide | 67 | $635 | $9 |
| Rosuvastatin | 18 | $621 | $34 |
| Omeprazole | 27 | $620 | $23 |
| Clopidogrel | 30 | $581 | $19 |
| Irbesartan | 15 | $574 | $38 |
| Metoprolol | 55 | $562 | $10 |
| Simvastatin | 40 | $513 | $13 |
| Nitroglycerin | 18 | $476 | $26 |
| Triamterene-Hydrochlorothiazid | 24 | $473 | $20 |
| Amlodipine Besylate | 48 | $464 | $10 |
| Levothyroxine | 16 | $460 | $29 |
| Atenolol | 48 | $412 | $9 |
| Zolpidem | 18 | $378 | $21 |
| Lisinopril | 43 | $361 | $8 |
| Escitalopram | 19 | $349 | $18 |
| Hydrochlorothiazide | 53 | $298 | $6 |
| Alprazolam | 12 | $257 | $21 |
| Fluticasone Propionate | 12 | $235 | $20 |
| Allopurinol | 11 | $185 | $17 |
| Lorazepam | 16 | $140 | $9 |
| Ranitidine | 12 | $139 | $12 |
| Metformin | 12 | $64 | $5 |
| Amoxicillin | 24 | $45 | $2 |
2017: 43 drugs
| Xarelto | 56 | $41,481 | $741 |
| Praluent | 21 | $30,783 | $1,466 |
| Eliquis | 42 | $28,758 | $685 |
| Sildenafil | 13 | $11,477 | $883 |
| Metoprolol | 72 | $4,512 | $63 |
| Brilinta | 12 | $4,055 | $338 |
| Valsartan | 43 | $2,942 | $68 |
| Ampicillin | 17 | $2,882 | $170 |
| Atorvastatin | 124 | $2,737 | $22 |
| Duloxetine | 13 | $2,595 | $200 |
| Warfarin | 82 | $2,103 | $26 |
| Polyethylene Glycol 3350 | 12 | $1,958 | $163 |
| Potassium Chloride | 41 | $1,520 | $37 |
| Oxycodone | 17 | $1,282 | $75 |
| Losartan | 83 | $1,154 | $14 |
| Amiodarone | 25 | $936 | $37 |
| Tamsulosin | 30 | $911 | $30 |
| Hydrocodone-Acetaminophen | 34 | $890 | $26 |
| Furosemide | 73 | $770 | $11 |
| Spironolactone | 34 | $758 | $22 |
| Carvedilol | 61 | $740 | $12 |
| Nitrostat | 12 | $725 | $60 |
| Ventolin Hfa | 13 | $698 | $54 |
| Zolpidem | 20 | $684 | $34 |
| Gabapentin | 26 | $657 | $25 |
| Metoprolol | 68 | $631 | $9 |
| Amlodipine Besylate | 53 | $543 | $10 |
| Clopidogrel | 33 | $484 | $15 |
| Atenolol | 44 | $402 | $9 |
| Allopurinol | 12 | $382 | $32 |
| Famotidine | 17 | $369 | $22 |
| Simvastatin | 30 | $368 | $12 |
| Omeprazole | 17 | $332 | $20 |
| Lorazepam | 24 | $331 | $14 |
| Hydrochlorothiazide | 52 | $322 | $6 |
| Fluticasone Propionate | 16 | $314 | $20 |
| Escitalopram | 21 | $254 | $12 |
| Lisinopril | 36 | $249 | $7 |
| Trazodone | 11 | $246 | $22 |
| Azithromycin | 11 | $196 | $18 |
| Metformin | 16 | $163 | $10 |
| Clonazepam | 17 | $81 | $5 |
| Amoxicillin | 13 | $51 | $4 |
2016: 43 drugs
| Xarelto | 61 | $42,828 | $702 |
| Eliquis | 24 | $13,168 | $549 |
| Zetia | 12 | $9,656 | $805 |
| Tenormin | 13 | $8,859 | $681 |
| Eplerenone | 16 | $4,711 | $294 |
| Metoprolol | 79 | $4,254 | $54 |
| Duloxetine | 22 | $3,453 | $157 |
| Pradaxa | 13 | $3,091 | $238 |
| Atorvastatin | 83 | $2,019 | $24 |
| Valsartan | 28 | $2,010 | $72 |
| Warfarin | 85 | $1,798 | $21 |
| Tamsulosin | 38 | $1,431 | $38 |
| Flecainide Acetate | 14 | $1,403 | $100 |
| Oxycodone | 22 | $1,137 | $52 |
| Potassium Chloride | 50 | $1,057 | $21 |
| Losartan | 67 | $875 | $13 |
| Digoxin | 16 | $815 | $51 |
| Carvedilol | 53 | $783 | $15 |
| Enalapril Maleate | 13 | $782 | $60 |
| Zolpidem | 28 | $781 | $28 |
| Spironolactone | 26 | $729 | $28 |
| Hydrocodone-Acetaminophen | 15 | $619 | $41 |
| Furosemide | 95 | $615 | $6 |
| Atenolol | 47 | $577 | $12 |
| Amlodipine Besylate | 61 | $536 | $9 |
| Gabapentin | 26 | $471 | $18 |
| Nitrostat | 17 | $445 | $26 |
| Amiodarone | 23 | $402 | $17 |
| Simvastatin | 38 | $370 | $10 |
| Lisinopril | 41 | $350 | $9 |
| Omeprazole | 29 | $336 | $12 |
| Escitalopram | 23 | $321 | $14 |
| Metoprolol | 56 | $318 | $6 |
| Hydrochlorothiazide | 45 | $268 | $6 |
| Clopidogrel | 18 | $244 | $14 |
| Nitroglycerin Patch | 12 | $228 | $19 |
| Metformin | 12 | $218 | $18 |
| Triamterene-Hydrochlorothiazid | 15 | $205 | $14 |
| Isosorbide Mononitrate Er | 11 | $190 | $17 |
| Lorazepam | 12 | $178 | $15 |
| Fluticasone Propionate | 11 | $178 | $16 |
| Alprazolam | 12 | $168 | $14 |
| Trazodone | 11 | $117 | $11 |
2015: 45 drugs
| Xarelto | 42 | $23,396 | $557 |
| Eliquis | 23 | $9,989 | $434 |
| Lipitor | 14 | $7,941 | $567 |
| Advair Diskus | 16 | $7,176 | $449 |
| Pradaxa | 29 | $5,792 | $200 |
| Metoprolol | 91 | $5,191 | $57 |
| Coreg | 13 | $3,838 | $295 |
| Pristiq Er | 12 | $3,462 | $288 |
| Tamsulosin | 43 | $3,395 | $79 |
| Eplerenone | 16 | $2,700 | $169 |
| Valsartan | 27 | $2,696 | $100 |
| Asmanex | 12 | $1,958 | $163 |
| Duloxetine | 19 | $1,932 | $102 |
| Warfarin | 94 | $1,866 | $20 |
| Atorvastatin | 53 | $1,809 | $34 |
| Digoxin | 46 | $1,393 | $30 |
| Potassium Chloride | 49 | $1,331 | $27 |
| Hydrocodone-Acetaminophen | 30 | $1,069 | $36 |
| Losartan | 63 | $1,065 | $17 |
| Proair Hfa | 14 | $773 | $55 |
| Xopenex Hfa | 12 | $721 | $60 |
| Carvedilol | 71 | $712 | $10 |
| Atenolol | 63 | $651 | $10 |
| Gabapentin | 32 | $646 | $20 |
| Furosemide | 91 | $637 | $7 |
| Lisinopril | 57 | $593 | $10 |
| Metoprolol | 44 | $463 | $11 |
| Escitalopram | 33 | $462 | $14 |
| Oxycodone | 11 | $446 | $41 |
| Levothyroxine | 13 | $403 | $31 |
| Fluticasone Propionate | 31 | $402 | $13 |
| Amlodipine Besylate | 36 | $364 | $10 |
| Zolpidem | 14 | $345 | $25 |
| Clopidogrel | 23 | $340 | $15 |
| Metformin | 13 | $294 | $23 |
| Spironolactone | 16 | $290 | $18 |
| Amiodarone | 15 | $245 | $16 |
| Pantoprazole | 13 | $235 | $18 |
| Simvastatin | 30 | $234 | $8 |
| Triamterene-Hydrochlorothiazid | 15 | $219 | $15 |
| Hydrochlorothiazide | 33 | $209 | $6 |
| Bupropion Hcl Sr | 15 | $142 | $9 |
| Clindamycin | 14 | $69 | $5 |
| Lorazepam | 18 | $53 | $3 |
| Amoxicillin | 12 | $48 | $4 |
2014: 49 drugs
| Samsca | 12 | $112,737 | $9,395 |
| Xarelto | 21 | $11,602 | $552 |
| Pradaxa | 43 | $11,035 | $257 |
| Lipitor | 16 | $5,764 | $360 |
| Fentanyl | 13 | $4,619 | $355 |
| Metoprolol | 79 | $4,332 | $55 |
| Diovan | 11 | $3,271 | $297 |
| Coreg | 11 | $2,359 | $214 |
| Pristiq Er | 11 | $2,356 | $214 |
| Duloxetine | 13 | $2,310 | $178 |
| Eplerenone | 13 | $2,044 | $157 |
| Telmisartan | 21 | $1,993 | $95 |
| Warfarin | 102 | $1,474 | $14 |
| Losartan | 57 | $1,440 | $25 |
| Amiodarone | 29 | $1,378 | $48 |
| Clopidogrel | 32 | $1,273 | $40 |
| Carvedilol | 72 | $1,139 | $16 |
| Atorvastatin | 39 | $1,120 | $29 |
| Cartia Xt | 18 | $1,099 | $61 |
| Tamsulosin | 32 | $1,058 | $33 |
| Gabapentin | 35 | $853 | $24 |
| Proair Hfa | 17 | $852 | $50 |
| Oxycodone-Acetaminophen | 16 | $815 | $51 |
| Atenolol | 77 | $805 | $10 |
| Digoxin | 23 | $765 | $33 |
| Potassium Chloride | 27 | $706 | $26 |
| Flecainide Acetate | 15 | $706 | $47 |
| Hydrocodone-Acetaminophen | 29 | $702 | $24 |
| Escitalopram | 25 | $670 | $27 |
| Lisinopril | 52 | $572 | $11 |
| Furosemide | 72 | $571 | $8 |
| Metoprolol | 59 | $542 | $9 |
| Amlodipine Besylate | 40 | $535 | $13 |
| Levothyroxine | 16 | $470 | $29 |
| Spironolactone | 23 | $467 | $20 |
| Sotalol | 12 | $428 | $36 |
| Fluticasone Propionate | 17 | $344 | $20 |
| Verapamil | 17 | $322 | $19 |
| Omeprazole | 21 | $271 | $13 |
| Simvastatin | 25 | $246 | $10 |
| Zolpidem | 27 | $237 | $9 |
| Oxybutynin Chloride | 13 | $228 | $18 |
| Triamterene-Hydrochlorothiazid | 12 | $215 | $18 |
| Hydrochlorothiazide | 29 | $183 | $6 |
| Allopurinol | 13 | $98 | $8 |
| Clonidine | 11 | $78 | $7 |
| Lorazepam | 18 | $67 | $4 |
| Clonazepam | 11 | $53 | $5 |
| Clindamycin | 13 | $33 | $3 |
2013: 42 drugs
| Samsca | 17 | $116,317 | $6,842 |
| Pradaxa | 57 | $13,486 | $237 |
| Lipitor | 25 | $7,353 | $294 |
| Fentanyl | 25 | $4,703 | $188 |
| Metoprolol | 69 | $4,023 | $58 |
| Celebrex | 13 | $3,349 | $258 |
| Diovan | 12 | $2,972 | $248 |
| Micardis | 14 | $2,920 | $209 |
| Cymbalta | 26 | $2,796 | $108 |
| Escitalopram | 27 | $2,777 | $103 |
| Cartia Xt | 13 | $1,738 | $134 |
| Coreg | 11 | $1,709 | $155 |
| Losartan | 42 | $1,614 | $38 |
| Gabapentin | 36 | $1,607 | $45 |
| Atorvastatin | 29 | $1,485 | $51 |
| Warfarin | 69 | $1,326 | $19 |
| Carvedilol | 67 | $1,279 | $19 |
| Spironolactone | 41 | $1,253 | $31 |
| Furosemide | 75 | $910 | $12 |
| Clopidogrel | 17 | $878 | $52 |
| Potassium Chloride | 30 | $828 | $28 |
| Tamsulosin | 21 | $678 | $32 |
| Omeprazole | 25 | $651 | $26 |
| Lisinopril | 51 | $581 | $11 |
| Metoprolol | 57 | $529 | $9 |
| Hydrocodone-Acetaminophen | 34 | $516 | $15 |
| Amlodipine Besylate | 50 | $511 | $10 |
| Atenolol | 48 | $471 | $10 |
| Diltiazem 24hr Er | 13 | $452 | $35 |
| Simvastatin | 17 | $340 | $20 |
| Levothyroxine | 20 | $325 | $16 |
| Fluticasone Propionate | 11 | $313 | $28 |
| Verapamil | 16 | $293 | $18 |
| Donepezil | 11 | $260 | $24 |
| Digox | 13 | $205 | $16 |
| Alprazolam | 12 | $182 | $15 |
| Hydrochlorothiazide | 14 | $140 | $10 |
| Digoxin | 11 | $132 | $12 |
| Lorazepam | 19 | $125 | $7 |
| Zolpidem | 16 | $95 | $6 |
| Oxybutynin Chloride | 11 | $84 | $8 |
| Clonidine | 16 | $80 | $5 |
Money from drug and device companies
$680 in 2025
| 2025 | 4 | 9 | None | $680 |
| 2024 | 2 | 3 | None | $70 |
| 2023 | 2 | 4 | $1,515 | $1,810 |
| 2021 | 2 | 3 | $5,298 | $5,298 |
| 2020 | 1 | 1 | None | $96 |
| 2019 | 2 | 15 | None | $1,550 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AtriCure | Epi-Sense Guided Coagulation System With Visitrax | $420 | 4 payments
|
| Medtronic | Avalus | $165 | 1 payment
|
| Siemens Medical Solutions USA | Acuson Origin Diagnostic Ultrasound System | $76 | 3 payments
|
| Canon Medical Systems USA | Diagnostic Ultrasound System | $19 | 1 payment
|
See all 9 published payments
| AtriCure | Meals · 2025-09-13 | Epi-Sense Guided Coagulation System With Visitrax | $103 |
| AtriCure | Meals · 2025-09-13 | Epi-Sense Guided Coagulation System With Visitrax | $53 |
| AtriCure | Meals · 2025-09-13 | Epi-Sense Guided Coagulation System With Visitrax | $89 |
| AtriCure | Meals · 2025-09-12 | Epi-Sense Guided Coagulation System With Visitrax | $175 |
| Siemens Medical Solutions USA | Meals · 2025-08-22 | Acuson Origin Diagnostic Ultrasound System | $29 |
| Siemens Medical Solutions USA | Meals · 2025-07-25 | Acuson Origin Diagnostic Ultrasound System | $22 |
| Siemens Medical Solutions USA | Meals · 2025-07-23 | Acuson Origin Diagnostic Ultrasound System | $25 |
| Medtronic | Meals · 2025-07-18 | Avalus | $165 |
| Canon Medical Systems USA | Meals · 2025-06-24 | Diagnostic Ultrasound System | $19 |
See earlier years (2024, 2023, 2021, 2020, 2019)
2024: $70
| Edwards Lifesciences | Evoque | $46 | 2 payments
|
| Ironwood Pharmaceuticals | Linzess | $24 | 1 payment
|
2023: $1,810
| Philips Electronics North America | (0107) Epiq 7c | $1,665 | 2 payments
|
| GE HealthCare | None | $145 | 2 payments
|
2021: $5,298
| Philips Electronics North America | Other | $4,798 | 2 payments
|
| Medtronic | None | $500 | 1 payment
|
2020: $96
| Merck Sharp & Dohme | Bridion | $96 | 1 payment
|
2019: $1,550
| Edwards Lifesciences | None | $1,486 | 13 payments
|
| Philips Electronics North America | Sector Undivided | $63 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Aytu BioPharma, Inc. · A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome (Veds) Confirmed With Col3a1 Mutations, Followed By An Open Label Extension (Ole) · 2023 | Their institution | $9,750 |
| Medtronic Vascular, Inc. · The Intrepid Tmvr Pilot S · 2019 | This clinician | $6,250 |
| Medtronic Vascular, Inc. · The Intrepid Tmvr Pilot S · 2020 | This clinician | $3,750 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 84.4 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1104966373
- Licence
- CA G69354California G69354: Current · expires 2027-09-30
- Trained
- Stanford University School of Medicine, 1989
- Group
- USC Care Medical Group Inc · Sutter Bay Medical Foundation
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 300 Pasteur Dr, Room H2157, Stanford, CA, 94305
- NPI first listed
- 2007-02-07
- NPI last updated
- 2014-12-09
This is when the NPI record was last certified, not a medical board exam.